News
OMass Therapeutics Presents Positive Preclinical Data For its Best-in-class MC2 Program at ENDO 2025
OMS1620 is advancing through IND-enabling studies for diseases associated with ACTH excess, including congenital adrenal ...
Espoo, Finland - Nokia today announced that three of its network APIs - Quality of Service on Demand, Number Verification, and Device Location Verification - are now available on Google Cloud ...
The Infinix HOT 60 Pro+ has officially entered the chat — at least if you're in Nigeria. The phone is now available for pre-order in the West African country ...
OMass is advancing a pipeline of small molecule therapeutics in rare diseases and immunological conditions. Its lead program is a best-in-class MC2 (melanocortin-2) receptor antagonist for the ...
TMCnet News OMass Therapeutics to Present New Preclinical Data For its Best-in-Class MC2 Program at ENDO 2025 [July 07, 2025] ...
This poster will be the first public data disclosure related to OMass’ MC2 receptor program and OMS1620, its development candidate currently in IND enabling studies.
This poster will be the first public data disclosure related to OMass’ MC2 receptor program and OMS1620, its development candidate currently in IND enabling studies. MC2R is a GPCR for the ...
Hurricane forecasters and scientists rely on weather data collected and processed by Department of Defense satellites. The Navy has decided to stop sharing the data.
The loss of access to the data could hamstring forecasters’ ability to track hurricanes and warn residents of their risk.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results